CBIO vs EQIX · $491.3M cap vs P/E 79, rev $9.22B
Crescent Biopharma, Inc. (CBIO) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
CBIO does not have a complete income-statement cache yet.
Latest reported EQIX revenue for 2025-12-31 was $9.22B. Net income was $1.35B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
CBIO currently screens at market cap $491.3M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the CBIO and EQIX stock pages for the full models.
Not investment advice.